Search - tctmd.com

Displaying 81 - 100 of 179

Sort: Relevancy | Date

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

Presenter: John P. Bois

March 23, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

Presenter: John P. Bois

March 23, 2019

Presentation ECHO/IMAGING 2019

Chamber Quantitation Guidelines: Left/Right Heart Measurements of Size and Function

Presenter: Gerard P. Aurigemma

March 22, 2019

News Conference News ACC 2019

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

L.A. McKeown

March 21, 2019

Presentation JIM 2019

Epicardial channel: Friend or Foe

Presenter: Ivan Wong

February 15, 2019

Presentation TCT Abstracts Posters 2018

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Presenter: Pravin Patil

September 25, 2018

Presentation SCAD 2018

Diagnosis of SCAD on CTA & MRI

Presenter: John R. Mayo

September 08, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation ECHO 2018

Evaluation of the Athlete

Presenter: Karen Stout

April 20, 2018

Presentation ECHO 2018

CMR for Valvular Heart Disease

Presenter: Omar Khalique

April 19, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

Presentation ECHO 2018

Chamber Quantitation Guidelines Update:Right Heart Measurements

Presenter: Linda D. Gillam

April 18, 2018

Presentation ECHO 2018

Quantitation of the Left Heart

Presenter: Gerard P. Aurigemma

April 18, 2018

News Industry News

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

April 16, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Daily News

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Michael O'Riordan

December 25, 2017

Presentation Controversies and Advances 2017

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Presenter: Balaji Tamarappoo

November 17, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Daily News

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Caitlin E. Cox

September 06, 2017

Advertisement

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

Chamber Quantitation Guidelines: Left/Right Heart Measurements of Size and Function

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

Epicardial channel: Friend or Foe

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Diagnosis of SCAD on CTA & MRI

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Evaluation of the Athlete

CMR for Valvular Heart Disease

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Chamber Quantitation Guidelines Update:Right Heart Measurements

Quantitation of the Left Heart

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content